Ra Medical Systems (NYSE:RMED) reported Q1 EPS of ($0.27), $0.10 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $100 thousand, versus $400 thousand reported last year.
Ra Medical reported cash and cash equivalents of $17.7 million as of March 31, 2022. In February 2022, the Company raised net proceeds of $9.7 million from a public offering after deducting offering costs paid and payable as of March 31, 2022.